Specialty Chemicals · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0.8% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Interest-bearing debt / market cap | 7.91% | < 30% | Pass |
| Interest-bearing investments / market cap | 11.73% | < 30% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0.8% of any dividend from ANURAS should be given to charity. Calculate your amount →
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.
ANURAS is drifting sideways with mild 6‑month gains but recent 1–3 month weakness. The price is mid-range from its 52‑week high with trend support still intact.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.